Mousa, M.H.A.; Ahmed, N.S.; Schwedtmann, K.; Frakolaki, E.; Vassilaki, N.; Zoidis, G.; Weigand, J.J.; Abadi, A.H.
Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors. Pharmaceuticals 2021, 14, 292.
https://doi.org/10.3390/ph14040292
AMA Style
Mousa MHA, Ahmed NS, Schwedtmann K, Frakolaki E, Vassilaki N, Zoidis G, Weigand JJ, Abadi AH.
Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors. Pharmaceuticals. 2021; 14(4):292.
https://doi.org/10.3390/ph14040292
Chicago/Turabian Style
Mousa, Mai H. A., Nermin S. Ahmed, Kai Schwedtmann, Efseveia Frakolaki, Niki Vassilaki, Grigoris Zoidis, Jan J. Weigand, and Ashraf H. Abadi.
2021. "Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors" Pharmaceuticals 14, no. 4: 292.
https://doi.org/10.3390/ph14040292
APA Style
Mousa, M. H. A., Ahmed, N. S., Schwedtmann, K., Frakolaki, E., Vassilaki, N., Zoidis, G., Weigand, J. J., & Abadi, A. H.
(2021). Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors. Pharmaceuticals, 14(4), 292.
https://doi.org/10.3390/ph14040292